WAM
SRPT icon

Wolverine Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Wolverine Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.4K Hold
4,920
– – ﹤0.01% 1183
2026
Q1 		$107K Sell
4,920
-9,317
-65% -$180K ﹤0.01% 1169
2025
Q4 		$306K Sell
14,237
-11,949
-46% -$252K ﹤0.01% 1042
2025
Q3 		$505K Buy
+26,186
New +$467K ﹤0.01% 875
2025
Q1 		– Sell
-1,636
Closed -$172K – 1767
2024
Q4 		$199K Sell
1,636
-3,676
-69% -$451K ﹤0.01% 1023
2024
Q3 		$663K Buy
+5,312
New +$734K 0.01% 801
2021
Q3 		– Sell
-329
Closed -$25.3K – 2331
2021
Q2 		$25K Buy
+329
New +$24.9K ﹤0.01% 1856
2020
Q3 		– Sell
-11
Closed -$1.67K – 1765
2020
Q2 		$1K Buy
+11
New +$1.5K ﹤0.01% 1499
2019
Q3 		– Sell
-388
Closed -$45.8K – 1615
2019
Q2 		$58K Sell
388
-11
-3% -$1.34K ﹤0.01% 1188
2019
Q1 		$47K Buy
+399
New +$51.3K ﹤0.01% 1188
2017
Q1 		– Sell
-3,800
Closed -$118K – 1373
2016
Q4 		$104K Sell
3,800
-100
-3% -$4.02K ﹤0.01% 933
2016
Q3 		$239K Buy
+3,900
New +$118K ﹤0.01% 841
2014
Q2 		– Sell
-33,500
Closed -$805K – 2530
2014
Q1 		$805K Buy
33,500
+23,700
+242% +$604K 0.02% 465
2013
Q4 		$199K Buy
+9,800
New +$291K ﹤0.01% 1154

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Wolverine Asset Management's SRPT Position: Q2 2026 in Review

Wolverine Asset Management held its Sarepta Therapeutics (SRPT) position steady in Q2 2026 at 4,920 shares worth $88.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1183.

Wolverine Asset Management first reported a position in SRPT in Q4 2013 and has held it in 14 quarters since. The position peaked at $805K in Q1 2014. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Wolverine Asset Management held 4,920 shares of Sarepta Therapeutics worth $88.4K as of Q2 2026.
  • Wolverine Asset Management left its Sarepta Therapeutics share count unchanged in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #1183 holding.
  • Wolverine Asset Management first reported a position in Sarepta Therapeutics in Q4 2013 and has held it in 14 quarters since.
  • Wolverine Asset Management's Sarepta Therapeutics position peaked at $805K in Q1 2014.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.